GENE ONLINE|News &
Opinion
Blog

2018-05-22|

May 22, 1989: NCI’s First Attempt to Genetically Engineer and Modify the Ability of Human Lymphocyte

by GeneOnline
Share To

On May 22, 1989, Dr. Steven A. Rosenberg, a scientist at the National Cancer Institute (NCI), performed the first human gene transfer trial in the history. Dr. Rosenberg implanted the human tumor-infiltrating lymphocytes with a foreign bacterial gene added to human body, and attempted to use genetic engineering to enhance the tracking and cytophagic abilities of lymphocytes.

Reference
https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-cancer-institute-nci

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Biotech in Beauty: Engineered Skin Bacteria Designed To Treat Acne
2024-05-10
R&D
UT Southwestern Study Unveils Acidic Defense Mechanism of Cancer Cells
2024-04-09
R&D
Efficient Phage Production System Promises Win Against Superbugs
2022-07-20
LATEST
NVIDIA’s Global AI Strategy: A Multi-Region Push with Taiwan and Middle East as Key Hubs
2025-05-22
MIRDC Establishes CDMO Innovation Center in Boston to Advance into Innovative Healthcare
2025-05-22
A Look at Taiwan-German Collaborative Solutions in Precision Medicine, Drug Development, and Medical Tech
2025-05-21
ACOG Updates Pain Management Guidelines for IUD Insertions as Novavax Vaccine Gains Approval
2025-05-20
NIH Restores Research Funding to Previously Defunded Scientists Amid Policy Shifts
2025-05-20
Prime Medicine Reduces Workforce by 25 Percent and Appoints David Schenkein as New CEO
2025-05-20
UnitedHealth Group Stock Drops Amid Rising Medicare Advantage Costs and Regulatory Debates
2025-05-20
EVENT
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top